He says: “There are a number of efforts to genetically modify mosquitoes so that they have collective death or so that they cannot carry certain diseases such as dengue or malaria.” “I am concerned about losing our control over some of these efforts, because mosquitoes – even although they carry bad diseases for people – occupy an ecosystem, as they are eaten by certain types of birds.”
There is a precedent for this type of genetic domination outside the reed cage. Asian carp,, Which were presented in the United States in the 1970s by the aquatic farming industry, is overwhelming in the Great Lakes, and other types swing. Burmese snakeAnd imported to the United States as strange pets, created a similar invasive position in Everglades, issued by the owners who are tired of their care.
The huge scientists pressed forward, and the company is already flourishing in its own adjustment position – not just as a scientific institution, but as a tremendous work. It has reached the case of decacorn, which is currently estimated at $ 10.2 billion, and although it may not be easy to liquefy mammoths, Dodo or a severe wolf puppy, Lamm sees many commercial capabilities in the technologies in which his scientific team develops. Colossal has operated two new companies so far. One, called breakUse microbes and engineering enzymes to break plastic waste. The other, Bio shapeProvides artificial intelligence platforms and arithmetic biology for the development of medicines. None of that is the basic experience of Colossal in cellular and genetic engineering, which has unlikely applications in the biological field, including treating and preventing diseases. “Genome engineering techniques alone are equal to tens of billions of dollars,” says Lam.